1-20 of 27
Timothy M.E. Davis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pulmonary Function Trajectories Over 6 Years and Their Determinants in Type 2 Diabetes: The Fremantle Diabetes Study Phase II

Timothy M.E. Davis, Jocelyn J. Drinkwater, Wendy A. Davis
Journal: Diabetes Care
Diabetes Care 2024;47(3):483–490
https://doi.org/10.2337/dc23-1726
Published: 11 January 2024
View article titled, Pulmonary Function Trajectories Over 6 Years and Their Determinants in Type 2 Diabetes: The Fremantle Diabetes Study Phase II
Open the PDF for Pulmonary Function Trajectories Over 6 Years and Their Determinants in Type 2 Diabetes: The Fremantle Diabetes Study Phase II in another window
Journal Articles

Temporal Trends in Incident Hospitalization for Diabetes-Related Foot Ulcer in Type 2 Diabetes: The Fremantle Diabetes Study

Emma J. Hamilton, Wendy A. Davis, Ranita Siru, Mendel Baba, Paul E. Norman, Timothy M.E. Davis
Journal: Diabetes Care
Diabetes Care 2021;44(3):722–730
https://doi.org/10.2337/dc20-1743
Published: 13 January 2021
View article titled, Temporal Trends in Incident Hospitalization for Diabetes-Related Foot Ulcer in Type 2 Diabetes: The Fremantle Diabetes Study
Open the PDF for Temporal Trends in Incident Hospitalization for Diabetes-Related Foot Ulcer in Type 2 Diabetes: The Fremantle Diabetes Study in another window
Journal Articles

Carotid Disease and Retinal Optical Coherence Tomography Angiography Parameters in Type 2 Diabetes: The Fremantle Diabetes Study Phase II

Jocelyn J. Drinkwater, Fred K. Chen, Alison M. Brooks, Brad T. Davis, Angus W. Turner, Timothy M.E. Davis, Wendy A. Davis
Journal: Diabetes Care
Diabetes Care 2020;43(12):3034–3041
https://doi.org/10.2337/dc20-0370
Published: 14 October 2020
View article titled, Carotid Disease and Retinal Optical Coherence Tomography Angiography Parameters in Type 2 Diabetes: The Fremantle Diabetes Study Phase II
Open the PDF for Carotid Disease and Retinal Optical Coherence Tomography Angiography Parameters in Type 2 Diabetes: The Fremantle Diabetes Study Phase II in another window
Journal Articles

Influence of Renin-Angiotensin System Inhibitors on Lower–Respiratory Tract Infections in Type 2 Diabetes: The Fremantle Diabetes Study Phase II

Timothy M.E. Davis, Wendy A. Davis
Journal: Diabetes Care
Diabetes Care 2020;43(9):2113–2120
https://doi.org/10.2337/dc20-0895
Published: 02 July 2020
View article titled, Influence of Renin-Angiotensin System Inhibitors on Lower–Respiratory Tract Infections in Type 2 Diabetes: The Fremantle Diabetes Study Phase II
Open the PDF for Influence of Renin-Angiotensin System Inhibitors on Lower–Respiratory Tract Infections in Type 2 Diabetes: The Fremantle Diabetes Study Phase II in another window
Journal Articles

Response to Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: the Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102–109

Wendy A. Davis, Emma J. Hamilton, David G. Bruce, Timothy M.E. Davis
Journal: Diabetes Care
Diabetes Care 2019;42(6):e101
https://doi.org/10.2337/dci19-0015
Published: 10 May 2019
View article titled, Response to Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: the Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102–109
Open the PDF for Response to Comment on Davis et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: the Fremantle Diabetes Study Phase I. Diabetes Care 2018;42:102–109 in another window
Journal Articles

Incidence and Determinants of Intraocular Lens Implantation in Type 2 Diabetes: The Fremantle Diabetes Study Phase II

Jocelyn J. Drinkwater, Timothy M.E. Davis, Angus W. Turner, David G. Bruce, Wendy A. Davis
Journal: Diabetes Care
Diabetes Care 2019;42(2):288–296
https://doi.org/10.2337/dc18-1556
Published: 06 December 2018
View article titled, Incidence and Determinants of Intraocular Lens Implantation in Type 2 Diabetes: The Fremantle Diabetes Study Phase II
Open the PDF for Incidence and Determinants of Intraocular Lens Implantation in Type 2 Diabetes: The Fremantle Diabetes Study Phase II in another window
Includes: Supplementary data
Journal Articles

Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I

Wendy A. Davis, Emma J. Hamilton, David G. Bruce, Timothy M.E. Davis
Journal: Diabetes Care
Diabetes Care 2019;42(1):102–109
https://doi.org/10.2337/dc18-1486
Published: 19 November 2018
View article titled, Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I
Open the PDF for Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I in another window
Includes: Supplementary data
Journal Articles

Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II

Kirsten E. Peters, Wendy A. Davis, Jun Ito, Kaye Winfield, Thomas Stoll, Scott D. Bringans, Richard J. Lipscombe, Timothy M.E. Davis
Journal: Diabetes Care
Diabetes Care 2017;40(11):1548–1555
https://doi.org/10.2337/dc17-0911
Published: 29 August 2017
View article titled, Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II
Open the PDF for Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II in another window
Includes: Supplementary data
Journal Articles

HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes

Boris Waldman, Alicia J. Jenkins, Timothy M.E. Davis, Marja-Riitta Taskinen, Russell Scott, Rachel L. O’Connell, Val J. Gebski, Martin K.C. Ng, Anthony C. Keech
Journal: Diabetes Care
Diabetes Care 2014;37(8):2351–2358
https://doi.org/10.2337/dc13-2738
Published: 12 July 2014
View article titled, HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes
Open the PDF for HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes in another window
Journal Articles

Continuing Disparities in Cardiovascular Risk Factors and Complications Between Aboriginal and Anglo-Celt Australians With Type 2 Diabetes: The Fremantle Diabetes Study

Timothy M.E. Davis, FRACP, Kerry Hunt, Daniel McAullay, PHD, Stephen A.P. Chubb, PHD, Brett A. Sillars, FRACP, David G. Bruce, FRACP, Wendy A. Davis, PHD
Journal: Diabetes Care
Diabetes Care 2012;35(10):2005–2011
https://doi.org/10.2337/dc12-0225
Published: 11 September 2012
View article titled, Continuing Disparities in Cardiovascular Risk Factors and Complications Between Aboriginal and Anglo-Celt Australians With Type 2 Diabetes: <subtitle>The Fremantle Diabetes Study</subtitle>
Open the PDF for Continuing Disparities in Cardiovascular Risk Factors and Complications Between Aboriginal and Anglo-Celt Australians With Type 2 Diabetes: <subtitle>The Fremantle Diabetes Study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes: Real-world diabetes therapy in a clinical trial cohort

James D. Best, MD, Paul L. Drury, FRACP, Timothy M.E. Davis, MRCP, Marja-Riitta Taskinen, MD, Y. Antero Kesäniemi, MD, Russell Scott, PHD, Christopher Pardy, BSC, Merryn Voysey, MBIOSTAT, Anthony C. Keech, FRACP, on behalf of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators
Journal: Diabetes Care
Diabetes Care 2012;35(5):1165–1170
https://doi.org/10.2337/dc11-1307
Published: 11 April 2012
View article titled, Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes: <subtitle>Real-world diabetes therapy in a clinical trial cohort</subtitle>
Open the PDF for Glycemic Control Over 5 Years in 4,900 People With Type 2 Diabetes: <subtitle>Real-world diabetes therapy in a clinical trial cohort</subtitle> in another window
Includes: Supplementary data
Journal Articles

Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: The FIELD Study

Ru-Dee Ting, FRACP, Anthony C. Keech, FRACP, Paul L. Drury, MA, Mark W. Donoghoe, BSC, John Hedley, FRACP, Alicia J. Jenkins, MD, Timothy M.E. Davis, FRACP, Seppo Lehto, MD, David Celermajer, MSC, R. John Simes, SM, Kushwin Rajamani, MB, Kim Stanton, FRACP, on behalf of the FIELD Study Investigators
Journal: Diabetes Care
Diabetes Care 2012;35(2):218–225
https://doi.org/10.2337/dc11-1109
Published: 16 January 2012
View article titled, Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: <subtitle>The FIELD Study</subtitle>
Open the PDF for Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: <subtitle>The FIELD Study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Maternal Family History of Diabetes Is Associated With a Reduced Risk of Cardiovascular Disease in Women With Type 2 Diabetes: The Fremantle Diabetes Study

David G. Bruce, MD, Kylie Van Minnen, BHlthSc, Wendy A. Davis, PHD, Jaspreet Mudhar, MBBS, Michael Perret, MBBS, Dayani P. Subawickrama, MBBS, Stephanie Venkitachalam, MBBS, David Ravine, PHD, Timothy M.E. Davis, DPHIL
Journal: Diabetes Care
Diabetes Care 2010;33(7):1477–1483
https://doi.org/10.2337/dc10-0147
Published: 05 April 2010
View article titled, Maternal Family History of Diabetes Is Associated With a Reduced Risk of Cardiovascular Disease in Women With Type 2 Diabetes: <subtitle>The Fremantle Diabetes Study</subtitle>
Open the PDF for Maternal Family History of Diabetes Is Associated With a Reduced Risk of Cardiovascular Disease in Women With Type 2 Diabetes: <subtitle>The Fremantle Diabetes Study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Aspirin Is Associated With Reduced Cardiovascular and All-Cause Mortality in Type 2 Diabetes in a Primary Prevention Setting: The Fremantle Diabetes Study

Greg Ong, MB, BS, Timothy M.E. Davis, FRACP, Wendy A. Davis, PHD
Journal: Diabetes Care
Diabetes Care 2010;33(2):317–321
https://doi.org/10.2337/dc09-1701
Published: 16 November 2009
View article titled, Aspirin Is Associated With Reduced Cardiovascular and All-Cause Mortality in Type 2 Diabetes in a Primary Prevention Setting: <subtitle>The Fremantle Diabetes Study</subtitle>
Open the PDF for Aspirin Is Associated With Reduced Cardiovascular and All-Cause Mortality in Type 2 Diabetes in a Primary Prevention Setting: <subtitle>The Fremantle Diabetes Study</subtitle> in another window
Journal Articles

Predictors of Cognitive Decline in Older Individuals With Diabetes

David G. Bruce, MD, Wendy A. Davis, PHD, Genevieve P. Casey, Sergio E. Starkstein, PHD, Roger M. Clarnette, MB, Osvaldo P. Almeida, PHD, Timothy M.E. Davis, DPHIL
Journal: Diabetes Care
Diabetes Care 2008;31(11):2103–2107
https://doi.org/10.2337/dc08-0562
Published: 01 November 2008
View article titled, Predictors of Cognitive Decline in Older Individuals With Diabetes
Open the PDF for Predictors of Cognitive Decline in Older Individuals With Diabetes in another window
Journal Articles

Prevalence, Characteristics, and Prognostic Significance of HFE Gene Mutations in Type 2 Diabetes: The Fremantle Diabetes Study

Timothy M.E. Davis, FRACP, John Beilby, PHD, Wendy A. Davis, PHD, John K. Olynyk, FRACP, Gary P. Jeffrey, FRACP, Enrico Rossi, PHD, Conchita Boyder, MSC, David G. Bruce, FRACP
Journal: Diabetes Care
Diabetes Care 2008;31(9):1795–1801
https://doi.org/10.2337/dc08-0248
Published: 01 September 2008
View article titled, Prevalence, Characteristics, and Prognostic Significance of <em>HFE</em> Gene Mutations in Type 2 Diabetes: <subtitle>The Fremantle Diabetes Study</subtitle>
Open the PDF for Prevalence, Characteristics, and Prognostic Significance of <em>HFE</em> Gene Mutations in Type 2 Diabetes: <subtitle>The Fremantle Diabetes Study</subtitle> in another window
Journal Articles

Hemodynamic Effects of Fenofibrate and Coenzyme Q10 in Type 2 Diabetic Subjects With Left Ventricular Diastolic Dysfunction

Gerard T. Chew, MD, Gerald F. Watts, DSC, Timothy M.E. Davis, DPHIL, Bronwyn G.A. Stuckey, MD, Lawrence J. Beilin, MD, Peter L. Thompson, MD, Valerie Burke, MD, Philip J. Currie, MD
Journal: Diabetes Care
Diabetes Care 2008;31(8):1502–1509
https://doi.org/10.2337/dc08-0118
Published: 01 August 2008
View article titled, Hemodynamic Effects of Fenofibrate and Coenzyme Q<sub>10</sub> in Type 2 Diabetic Subjects With Left Ventricular Diastolic Dysfunction
Open the PDF for Hemodynamic Effects of Fenofibrate and Coenzyme Q<sub>10</sub> in Type 2 Diabetic Subjects With Left Ventricular Diastolic Dysfunction in another window
Journal Articles

Incidence and Determinants of Carpal Tunnel Decompression Surgery in Type 2 Diabetes: The Fremantle Diabetes Study

Ashley Makepeace, MBBS, Wendy A. Davis, MPH, PHD, David G. Bruce, MD, FRACP, Timothy M.E. Davis, PHD, FRACP
Journal: Diabetes Care
Diabetes Care 2008;31(3):498–500
https://doi.org/10.2337/dc07-2058
Published: 01 March 2008
View article titled, Incidence and Determinants of Carpal Tunnel Decompression Surgery in Type 2 Diabetes: <subtitle>The Fremantle Diabetes Study</subtitle>
Open the PDF for Incidence and Determinants of Carpal Tunnel Decompression Surgery in Type 2 Diabetes: <subtitle>The Fremantle Diabetes Study</subtitle> in another window
Journal Articles

An Assessment of Eligibility for Inhaled Insulin (Exubera): The Fremantle Diabetes Study

Timothy M.E. Davis, FRACP, Wendy A. Davis, PHD
Journal: Diabetes Care
Diabetes Care 2007;30(2):360–361
https://doi.org/10.2337/dc06-1704
Published: 01 February 2007
View article titled, An Assessment of Eligibility for Inhaled Insulin (Exubera): <subtitle>The Fremantle Diabetes Study</subtitle>
Open the PDF for An Assessment of Eligibility for Inhaled Insulin (Exubera): <subtitle>The Fremantle Diabetes Study</subtitle> in another window
Journal Articles

Is Self-Monitoring of Blood Glucose Appropriate for All Type 2 Diabetic Patients? The Fremantle Diabetes Study: Response to Kolb et al.

Wendy A. Davis, PHD, David G. Bruce, MD, Timothy M.E. Davis, D PHIL
Journal: Diabetes Care
Diabetes Care 2007;30(1):184–185
https://doi.org/10.2337/dc06-1992
Published: 01 January 2007
View article titled, Is Self-Monitoring of Blood Glucose Appropriate for All Type 2 Diabetic Patients? The Fremantle Diabetes Study: <subtitle>Response to Kolb et al.</subtitle>
Open the PDF for Is Self-Monitoring of Blood Glucose Appropriate for All Type 2 Diabetic Patients? The Fremantle Diabetes Study: <subtitle>Response to Kolb et al.</subtitle> in another window